Marie Péan de Ponfilly-Sotier, Vincent Jachiet, Y. Benhamou, Constance Lahuna, Benoît de Renzis, D. Kottler, Laurent Voillat, Sophie Dimicoli‐Salazar, Anne Banos, Marie‐Paule Chauveheid, Jean‐François Alexandra, Éric Grignano, François Liferman, Mathilde Laborde, Jonathan Broner, Marc Michel, Olivier Lambotte, Kamel Laribi, Marie‐Dominique Venon, Bertrand Dussol, Nihal Martis, Sylvain Thépot, Sophie Park, David Couret, Marielle Roux-Sauvat, Louis Terriou, É. Hachulla, Cécile Bally, Joris Galland, Jean‐Sébastien Allain, Anne Parcelier, Pierre Péterlin, Judith Cohen‐Bittan, Alexis Régent, Félix Ackermann, J. Le Guen, Caroline Algrin, Pierre Charles, Étienne Daguindau, Xavier Puéchal, Bertrand Dunogué, Claire Blanchard‐Delaunay, Odile Beyne‐Rauzy, Vincent Grobost, J. Schmidt, Thomas Le Gallou, Georgeta Dubos-Lascu, Anne Sonet, Guillaume Denis, F. Roy-Péaud, Pierre Fenaux, Lionel Adès, O. Fain, A. Mékinian,
Myelodysplastic syndromes (MDS) and chronic myelomonocytic leukaemia (CMML) are associated with systemic inflammatory and autoimmune diseases (SIADs) in 10-30% of cases. The aims of this study were (i) to evaluate the prevalence of venous thromboembolism VTE in patients presenting with both MDS/CMML and SIADs, (ii) to describe risk factors associated with thrombosis, and (iii) to analyse the impact of VTE on overall survival and transformation to acute myeloid leukaemia in comparison to patients with ...
Tópico(s): Autoimmune and Inflammatory Disorders Research
2021 - Springer Vienna | Clinical and Experimental Rheumatology